Pamela L. Cox
Partner
Pamela L. Cox concentrates on counseling related to intellectual property transactions, protection and transfer for clients ranging from multinational corporations to non-profit institutions. As a patent attorney who has managed intellectual property portfolios in-house, Ms. Cox understands her clients’ intellectual property and agreement needs, and remains passionately engaged until achieving their strategic objectives. Clients find her talented at unraveling complex deal structures and devising creative agreement solutions as a seamless member of their team.
"Pamela Cox is one of the foremost licensing experts both in the Midwest and nationally. She is a pre-eminent authority on university technology transfer and licensing acting for commercial and non-profit clients." – IAM Patent 1000
Case Studies and Client Successes
- For more a decade, represented MonoSol, LLC in its intellectual property litigation, prosecution and transactional matters, including in its recent acquisition by Kuraray Holdings U.S.A., Inc.
- Led the negotiations for NUtech Ventures in their collaboration license and germplasm transfer agreement with Bayer CropScience AG that focuses on wheat improvement, makes provision for an endowed professorship at the University of Nebraska-Lincoln, support for UNL research and education programs, support for UNL's first Presidential chair named for the Nebraska Wheat Growers, and plans for Bayer to establish its first North American wheat-breeding station near Lincoln.
- Manage the Firm’s IP services to Northwestern University for the patent portfolio of Chad Mirkin’s laboratory, who is the most-cited chemist in the world and nanomedicine researcher in the world. Led the Northwestern University team in negotiating portfolio license agreements under these patent portfolios to AuraSense LLC, Nanosphere Inc. and NanoInk Inc.
- Developed, restructured, interpreted and advised Scott & White Healthcare, one of the nation's largest multi-center healthcare systems, on numerous university, institute, foundation and hospital intellectual property policies, drawing on the Firm’s depth of understanding of prosecution and litigation matters related to inventorship, ownership and non-profit technology transfer.
- Represent Orion Genomics in their multi-year collaboration on the Oil Palm Genome with the Malaysian Palm Oil Board. The results of this collaboration are an essential step toward improved production of food, feed and fuel in this important crop.
- Represented Loyola University of Chicago when its ownership was unsuccessfully challenged by MediGene AG and negotiated Loyola's current license with GlaxoSmithKline who now manufactures and sells Cervarix® (Human papillomavirus bivalent vaccine, recombinant).
- Structure and negotiate agreements to out-license Chinese hamster EF-1 alpha regulatory DNA (CHEF1) intellectual and tangible property for CMC ICOS Biologics, Inc. through evolving business models over the life-cycle of the more than a dozen issued patents around the world.
Pamela L. Cox
Partner
Pamela L. Cox concentrates on counseling related to intellectual property transactions, protection and transfer for clients ranging from multinational corporations to non-profit institutions. As a patent attorney who has managed intellectual property portfolios in-house, Ms. Cox understands her clients’ intellectual property and agreement needs, and remains passionately engaged until achieving their strategic objectives. Clients find her talented at unraveling complex deal structures and devising creative agreement solutions as a seamless member of their team.
"Pamela Cox is one of the foremost licensing experts both in the Midwest and nationally. She is a pre-eminent authority on university technology transfer and licensing acting for commercial and non-profit clients." – IAM Patent 1000
- T.312.423.3451
- F.312.474.0448


Case Studies and Client Successes
- For more a decade, represented MonoSol, LLC in its intellectual property litigation, prosecution and transactional matters, including in its recent acquisition by Kuraray Holdings U.S.A., Inc.
- Led the negotiations for NUtech Ventures in their collaboration license and germplasm transfer agreement with Bayer CropScience AG that focuses on wheat improvement, makes provision for an endowed professorship at the University of Nebraska-Lincoln, support for UNL research and education programs, support for UNL's first Presidential chair named for the Nebraska Wheat Growers, and plans for Bayer to establish its first North American wheat-breeding station near Lincoln.
- Manage the Firm’s IP services to Northwestern University for the patent portfolio of Chad Mirkin’s laboratory, who is the most-cited chemist in the world and nanomedicine researcher in the world. Led the Northwestern University team in negotiating portfolio license agreements under these patent portfolios to AuraSense LLC, Nanosphere Inc. and NanoInk Inc.
- Developed, restructured, interpreted and advised Scott & White Healthcare, one of the nation's largest multi-center healthcare systems, on numerous university, institute, foundation and hospital intellectual property policies, drawing on the Firm’s depth of understanding of prosecution and litigation matters related to inventorship, ownership and non-profit technology transfer.
- Represent Orion Genomics in their multi-year collaboration on the Oil Palm Genome with the Malaysian Palm Oil Board. The results of this collaboration are an essential step toward improved production of food, feed and fuel in this important crop.
- Represented Loyola University of Chicago when its ownership was unsuccessfully challenged by MediGene AG and negotiated Loyola's current license with GlaxoSmithKline who now manufactures and sells Cervarix® (Human papillomavirus bivalent vaccine, recombinant).
- Structure and negotiate agreements to out-license Chinese hamster EF-1 alpha regulatory DNA (CHEF1) intellectual and tangible property for CMC ICOS Biologics, Inc. through evolving business models over the life-cycle of the more than a dozen issued patents around the world.


